Increasing Incidence of Anemia is driving the Folic Acid Market

The global folic acid market is estimated to grow at a CAGR of nearly 4.5% during the forecast period (2024-2031). The market growth is driven by the significant prevalence of anemia and emerging applications in pharmaceuticals and dietary supplements. Additionally, the emerging focus on folic acid in cosmetics is presenting considerable opportunities for market growth during the forecast period. The global folic acid market is segmented by form (tablets, capsules, soft gels, powder, and others), by application (dietary supplements, pharmaceuticals, food and beverages, and others), and geography (North America, Europe, Asia-Pacific, and the Rest of the World). 

Market Dynamics

• The pharmaceutical segment is anticipated to dominate the market during the forecast period, owing to the increasing prevalence of anemia. 

• Asia-Pacific is estimated to hold a potential share in the market owing to the significant number of patients with anemia and the emerging demand for folic acid-based nutraceuticals. Additionally, increasing demand for plant-based antioxidants in skincare products is further driving the regional market growth.

• Europe is estimated to grow significantly owing to the significant presence of major food and beverage and pharmaceutical companies in the region.

The key players in the global folic acid market are contributing significantly to the market growth by providing different types of products and increasing their geographical presence.  The key players in the market include Koninklijke DSM N.V., BASF SE, Cadila Healthcare Ltd., Merck KGaA, and Jiangxi Tianxin Pharmaceutical Co., Ltd., among others.    

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/folic-acid-market